Medicare Approved Facilities/Trials/Registries ICD Registry
Guidance for Approved Facilities/Trials/Registries on coverage for implantable cardioverter defibrillators (ICDs).
Final
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: February 15, 2018
Medicare provides coverage for implantable cardioverter defibrillators (ICDs) for certain patients and clinical indications. Detailed descriptions of the covered indications are available in the National Coverage Determination (NCD).
The initial data collection requirement through the American College of Cardiology's National Cardiovascular Data Registry (ACC-NCDR) has served to develop and improve the evidence base for the use of ICDs in certain Medicare beneficiaries. The data collection requirement ended with the posting of the final decision memo for Implantable Cardioverter Defibrillators on February 15, 2018. We encourage the continuation and improvement of a voluntary registry for purposes of quality improvement, safety, and appropriate use verification.
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.